Literature DB >> 3881952

Reversal of Bartter's syndrome by renal transplantation in a child with focal, segmental glomerular sclerosis.

S L Blethen, J J Van Wyk, W B Lorentz, J C Jennette.   

Abstract

A four-year-old girl with growth failure and clinical and laboratory evidence of Bartter's syndrome responded to indomethacin treatment with decreased urinary prostaglandin excretion, symptomatic and chemical improvement, and accelerated growth. Large doses of aspirin produced a comparable decrease in prostaglandin excretion but no improvement in any other metabolic abnormality thus suggesting that abnormalities in prostaglandins were the result rather than the cause of the electrolyte abnormalities. Progressive renal insufficiency while on indomethacin prompted a renal biopsy, which revealed morphological changes of focal, segmental glomerular sclerosis. Subsequently, the child underwent renal transplantation with complete resolution of symptoms and abnormal metabolic findings. This observation suggests that extrarenal factors were not responsible for the development of Bartter's syndrome in this child.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881952     DOI: 10.1097/00000441-198501000-00006

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  7 in total

1.  C1q nephropathy in association with Gitelman syndrome: a case report.

Authors:  Coral Hanevold; Ayesa Mian; Rory Dalton
Journal:  Pediatr Nephrol       Date:  2006-09-06       Impact factor: 3.714

2.  Clinical and Genetic Spectrum of Bartter Syndrome Type 3.

Authors:  Elsa Seys; Olga Andrini; Mathilde Keck; Lamisse Mansour-Hendili; Pierre-Yves Courand; Christophe Simian; Georges Deschenes; Theresa Kwon; Aurélia Bertholet-Thomas; Guillaume Bobrie; Jean Sébastien Borde; Guylhène Bourdat-Michel; Stéphane Decramer; Mathilde Cailliez; Pauline Krug; Paul Cozette; Jean Daniel Delbet; Laurence Dubourg; Dominique Chaveau; Marc Fila; Noémie Jourde-Chiche; Bertrand Knebelmann; Marie-Pierre Lavocat; Sandrine Lemoine; Djamal Djeddi; Brigitte Llanas; Ferielle Louillet; Elodie Merieau; Maria Mileva; Luisa Mota-Vieira; Christiane Mousson; François Nobili; Robert Novo; Gwenaëlle Roussey-Kesler; Isabelle Vrillon; Stephen B Walsh; Jacques Teulon; Anne Blanchard; Rosa Vargas-Poussou
Journal:  J Am Soc Nephrol       Date:  2017-04-05       Impact factor: 10.121

3.  A patient with Bartter syndrome accompanying severe growth hormone deficiency and focal segmental glomerulosclerosis.

Authors:  Ipek Akil; Serkan Ozen; Ali Riza Kandiloglu; Betul Ersoy
Journal:  Clin Exp Nephrol       Date:  2010-02-04       Impact factor: 2.801

4.  Renal transplantation in a patient with Bartter syndrome and glomerulosclerosis.

Authors:  Se Eun Lee; Kyoung Hee Han; Yun Hye Jung; Hyun Kyung Lee; Hee Gyung Kang; Kyung Chul Moon; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Korean J Pediatr       Date:  2011-01-31

Review 5.  Genetic Heterogeneity in Bartter Syndrome: Clinical and Practical Importance.

Authors:  Laura Florea; Lavinia Caba; Eusebiu Vlad Gorduza
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

Review 6.  Bartter syndrome complicated by immune complex nephropathy. Case report and literature review.

Authors:  Yahya Sardani; Kenan Qin; Mark Haas; Andrew J Aronson; Robert L Rosenfield
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

7.  Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis.

Authors:  Hajime Yamazaki; Kandai Nozu; Ichiei Narita; Michio Nagata; Yoshimi Nozu; Xue Jun Fu; Masafumi Matsuo; Kazumoto Iijima; Fumitake Gejyo
Journal:  Pediatr Nephrol       Date:  2008-10-02       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.